It may be frustrating to see a stock you hold not trading but...

It may be frustrating to see a stock you hold not trading but when I look around at the sector & the broader markets I'm reminded how fortunate CGB is to not be trading over the last 6 months.

People can debate to the cows come home about atleast having options to trade & analogies about ships in the harbour bla bla bla but you will not convince me otherwise that the CGB share price has not been protected during this prolonged re-compliance process.

I think many of the mm stocks have suffered from inflated market caps against little or no returns, I fear CGB would have suffered equally.

The bright light for CGB shareholders for me is that despite not trading the day to day runnings of the business have continued developing the business.

It has been a real opportunity for CGB to build towards producing revenue whilst preserving their existing market cap.

If our hemp division can start producing a few successful harvests & the BioHealth expansion is approved & successful than CGB shareholders prospects of a much higher sp against an otherwise depressed spec market is greatly increased.

I'm not a holder of EXL but hopefully CGB can share similar sp success once our hemp/consumables start generating significant revenue. Obviously EXL was a more mature company than CGB at the time of its listing on the ASX.

I believe having our hemp/consumables is a massive insurance for CGB shareholders against an infant mm market that will require time to reach its full potential.

Let's just let Andrew, Sholom & team do what they need to do.

I'm patient..I can wait for this to become the mammoth it's destined to be.